{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:50:31Z","timestamp":1772121031864,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jcv.2022.105150","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:51:17Z","timestamp":1649105477000},"page":"105150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Performance of the cobas\u00ae HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients"],"prefix":"10.1016","volume":"150-151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-8480","authenticated-orcid":false,"given":"Caroline","family":"Scholt\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron T.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Plissonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Charre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Berby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslava","family":"Subic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hoppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Lankenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Grubenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Levrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marintha L.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2022.105150_bib0001","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/infdis\/jiaa136","article-title":"Combining hepatitis B virus RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in hepatitis b e antigen-positive patients with chronic hepatitis B","volume":"222","author":"Fan","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105150_bib0002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cgh.2019.07.046","article-title":"Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy","volume":"18","author":"Fan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105150_bib0003","article-title":"Hepatitis B virus RNA as early predictor for response to PEGylated interferon alfa in HBeAg negative chronic hepatitis B","author":"Farag","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105150_bib0004","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2147\/IDR.S252994","article-title":"Serum hepatitis B virus RNA levels predict HBeAg seroconversion and virological response in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analog","volume":"13","author":"Ji","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jcv.2022.105150_bib0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jcv.2022.105150_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104553","article-title":"Non-invasive biomarkers for chronic hepatitis B virus infection management","volume":"169","author":"Charre","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2022.105150_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/v13060951","article-title":"Novel biomarkers of hepatitis B virus and their use in chronic hepatitis B patient management","volume":"13","author":"Vachon","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2022.105150_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25792","article-title":"Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification","author":"Limothai","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2022.105150_bib0009","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/hep.30082","article-title":"Hepatitis B virus serum DNA and RNA levels in nucleos(t)ide analog-treated or untreated patients during chronic and acute infection","volume":"68","author":"Butler","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105150_bib0010","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/JCM.36.12.3590-3594.1998","article-title":"Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards","volume":"36","author":"Pasloske","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105150_bib0011","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1373\/clinchem.2004.035519","article-title":"Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance","volume":"50","author":"Stocher","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jcv.2022.105150_bib0012","unstructured":"ClinicalTrals.gov, creation of a cohort for the quantitation and characterization of circulating viral RNAs as a new biomarker of hepatitis B functional cure. (CirB-RNA). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03825458. 2019 (accessed November 10)."},{"key":"10.1016\/j.jcv.2022.105150_bib0013","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European association for the study of the liver, EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105150_bib0014","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JCM.00760-17","article-title":"Serum hepatitis B virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment?","volume":"55","author":"Gao","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105150_bib0015","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jvh.12908","article-title":"Natural history of serum HBV-RNA in chronic HBV infection","volume":"25","author":"Wang","year":"2018","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jcv.2022.105150_bib0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jiv397","article-title":"Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos(t)ide analogues","volume":"213","author":"Jansen","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105150_bib0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.27381","article-title":"Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors","volume":"61","author":"van Bommel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105150_bib0018","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/infdis\/jiy270","article-title":"Serum HBV RNA as a predictor of peginterferon alfa-2a response in patients with HBeAg-positive chronic hepatitis B","volume":"218","author":"van Bommel","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105150_bib0019","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cgh.2019.08.044","article-title":"Should level of HBV RNA be used to determine when patients should stop treatment with nucleos(t)ide analogues","volume":"18","author":"Otsuka","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105150_bib0020","article-title":"Quantification of HEV RNA by droplet digital PCR","volume":"8","author":"Nicot","year":"2016","journal-title":"VirusesViruses"},{"key":"10.1016\/j.jcv.2022.105150_bib0021","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/hep.32018","article-title":"Comparison of HBV RNA and hepatitis B core related antigen with conventional HBV markers among untreated adults with chronic hepatitis B in North America","volume":"74","author":"Ghany","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105150_bib0022","article-title":"Cross-sectional study of serum HBV RNA and HBcrAg in a real-life prospective cohort of 1500 chronic hepatitis B patients followed in France and Italy","author":"Zoulim","year":"2021","journal-title":"The Liver Meeting (AASLD)"},{"key":"10.1016\/j.jcv.2022.105150_bib0023","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/cid\/ciaa1015","article-title":"Circulating pregenomic hepatitis B virus RNA is primarily full-length in chronic hepatitis B patients undergoing nucleos(t)ide analogue therapy","volume":"72","author":"Anderson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105150_bib0024","unstructured":"Fryer J.F., Minhas R., Dougall T., Rigsby P., Clare L., Morris C.L., Collaborative study to evaluate the proposed WHO 4th international standard for hepatitis B virus (HBV) DNA for nucleic acid amplification technique (NAT) based assays. https:\/\/apps.who.int\/iris\/handle\/10665\/253052. 2016 (accessed December 7)."},{"key":"10.1016\/j.jcv.2022.105150_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01056-18","article-title":"Standardization of nucleic acid tests: the approach of the world health organization","volume":"57","author":"Baylis","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105150_bib0026","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/trf.14026","article-title":"Zika virus collaborative study g, harmonization of nucleic acid testing for zika virus: development of the 1(st) world health organization international standard","volume":"57","author":"Baylis","year":"2017","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jcv.2022.105150_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12985-018-0994-7","article-title":"High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles","volume":"15","author":"Prakash","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.jcv.2022.105150_bib0028","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105150_bib0029","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.29872","article-title":"Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment","volume":"68","author":"van Campenhout","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105150_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12876-019-0966-4","article-title":"Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105150_bib0031","article-title":"Circulating HBV RNA correlates with intrahepatic covalently closed circular DNA (cccDNA) levels and activity in untreated chronic hepatitis B (CHB) patients","author":"Testoni","year":"2021","journal-title":"The International Liver Congress (EASL)"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322200083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322200083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:14Z","timestamp":1761362174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665322200083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":31,"alternative-id":["S138665322200083X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105150","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.09.483670","asserted-by":"object"}]},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the cobas\u00ae HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105150"}}